1. Aptekar, R. Gv Atkinson, J. P., Decker, J. L., Wolff, S. M., and Chu, E. W.: Bladder toxicity with chronic oral cyclophosphamide therapy in non-malignant diseases. Arthritis Rheum. 16:461–67, 1973.
2. Arnold, H.: UeberdieChemie neuer zytostatisch wirksamer N-Chloroaethyl-phosphorsäureesterdiamide, in Proceedings of the Fifth International Congress Chemotherapy, K. Spitzy and H. Haschek, eds., pp. 751–754, Verlag der Wiener Medizinischen-Akad.; Vienna, 1967.
3. Arnold, H., Bourseaux, F., and Brock, N.: Neuartige Krebs-Chemotherap-eutika aus der Gruppe der zyklischen N-lost-phosphamidester. Naturwissenschaften
45:64–66, 1958a.
4. Arnold, H., Bourseaux, F., and Brock, N.: Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B518-ASTA) in experimental tumors of the rat. Nature
181:931, 1958b.
5. Bennett, D. R., ed.: AMA Drug Evaluations, 5th Ed., American Medical Association, Chicago, 1983.